+32.2%
CVS vs SPMO
+149.5%
-117.3%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SPMO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | +0.5% | -1.2% | -0.8% |
| 7D | -2.2% | -0.9% | -1.2% | -1.9% |
| 30D | -0.1% | -1.9% | +1.9% | +0.4% |
| 3M | -5.2% | -1.4% | -3.9% | -5.4% |
| 6M | +26.9% | +25.5% | +1.4% | +15.6% |
| YTD | +22.1% | +24.8% | -2.8% | +11.3% |
| 1Y | +30.8% | +24.5% | +6.3% | +19.2% |
| 3Y | +54.4% | +157.1% | -102.7% | -5.1% |
| All | +32.2% | +149.5% | -117.3% | -19.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SPMO.
Daily Out/Under-Performance
Portfolio return minus SPMO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPMO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SPMO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling